Disclosures for "Biomarkers as prognostic determinants of epilepsy after post-acute central nervous system insults: a systematic review and meta-analysis")
-
Mr. Misra has nothing to disclose.
-
Ms. Khan has nothing to disclose.
-
The institution of Dr. Lam has received research support from NIH.
-
Dr. Mazumder has nothing to disclose.
-
Ms. Eldem has nothing to disclose.
-
Dr. Gururangan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Gururangan has stock in Ceribell Inc. The institution of Dr. Gururangan has received research support from NIH-NINDS. The institution of Dr. Gururangan has received research support from Leon Levy Foundation.
-
Dr. Hickman has nothing to disclose.
-
Dr. Goswami has nothing to disclose.
-
Mrs. Funaro has nothing to disclose.
-
The institution of Joan Montaner has received research support from spanish govt. Joan Montaner has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Quinn has nothing to disclose.
-
Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
-
Dr. Mishra has nothing to disclose.